AMLX
Price
$7.81
Change
+$0.17 (+2.23%)
Updated
Aug 11, 11:40 AM (EDT)
Capitalization
681.24M
87 days until earnings call
LVTX
Price
$1.52
Change
-$0.01 (-0.65%)
Updated
Aug 11, 04:48 PM (EDT)
Capitalization
40.25M
15 days until earnings call
Interact to see
Advertisement

AMLX vs LVTX

Header iconAMLX vs LVTX Comparison
Open Charts AMLX vs LVTXBanner chart's image
Amylyx Pharmaceuticals
Price$7.81
Change+$0.17 (+2.23%)
Volume$252
Capitalization681.24M
LAVA Therapeutics
Price$1.52
Change-$0.01 (-0.65%)
Volume$200
Capitalization40.25M
AMLX vs LVTX Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. LVTX commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and LVTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (AMLX: $7.64 vs. LVTX: $1.53)
Brand notoriety: AMLX and LVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 56% vs. LVTX: 298%
Market capitalization -- AMLX: $681.24M vs. LVTX: $40.25M
AMLX [@Biotechnology] is valued at $681.24M. LVTX’s [@Biotechnology] market capitalization is $40.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileLVTX’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • LVTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both AMLX and LVTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while LVTX’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • LVTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LVTX is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а -0.97% price change this week, while LVTX (@Biotechnology) price change was +7.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.35%. For the same industry, the average monthly price growth was +31.87%, and the average quarterly price growth was +19.42%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

LVTX is expected to report earnings on Aug 26, 2025.

Industries' Descriptions

@Biotechnology (+22.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($681M) has a higher market cap than LVTX($40.2M). AMLX YTD gains are higher at: 102.116 vs. LVTX (60.883). LVTX has higher annual earnings (EBITDA): -26.26M vs. AMLX (-206.81M). AMLX has more cash in the bank: 204M vs. LVTX (66.6M). LVTX has less debt than AMLX: LVTX (312K) vs AMLX (1.38M). LVTX has higher revenues than AMLX: LVTX (4.99M) vs AMLX (-1.27M).
AMLXLVTXAMLX / LVTX
Capitalization681M40.2M1,694%
EBITDA-206.81M-26.26M788%
Gain YTD102.11660.883168%
P/E Ratio2.81N/A-
Revenue-1.27M4.99M-25%
Total Cash204M66.6M306%
Total Debt1.38M312K443%
TECHNICAL ANALYSIS
Technical Analysis
AMLXLVTX
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 6 days ago
79%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 13 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MPDIX12.450.13
+1.06%
MassMutual Disciplined Gr I
BGSIX78.850.38
+0.48%
BlackRock Technology Opportunities Instl
MXHTX10.100.01
+0.10%
Empower International Growth Instl
FSMVX29.65N/A
N/A
Fidelity Mid Cap Value
AAEMX12.02-0.06
-0.50%
Alger Emerging Markets A

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with GRI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-2.55%
GRI - AMLX
57%
Loosely correlated
+0.80%
SLRX - AMLX
54%
Loosely correlated
-10.07%
RGNX - AMLX
45%
Loosely correlated
-0.63%
LRMR - AMLX
43%
Loosely correlated
-2.19%
ADVM - AMLX
43%
Loosely correlated
-6.53%
More

LVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LVTX has been loosely correlated with VIVS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LVTX jumps, then VIVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVTX
1D Price
Change %
LVTX100%
N/A
VIVS - LVTX
42%
Loosely correlated
-0.11%
JBPHF - LVTX
38%
Loosely correlated
N/A
TCRX - LVTX
37%
Loosely correlated
-0.61%
OPORF - LVTX
32%
Poorly correlated
N/A
AMLX - LVTX
31%
Poorly correlated
-2.55%
More